Abstract

The unresolved and paramount challenge in bio-imaging and targeted therapy is to clearly define and demarcate the physical margins of tumor tissue. The ability to outline the healthy vital tissues to be carefully navigated with transection while an intraoperative surgery procedure is performed sets up a necessary and under-researched goal. To achieve the aforementioned objectives, there is a need to optimize design considerations in order to not only obtain an effective imaging agent but to also achieve attributes like favorable water solubility, biocompatibility, high molecular brightness, and a tissue specific targeting approach. The emergence of near infra-red fluorescence (NIRF) light for tissue scale imaging owes to the provision of highly specific images of the target organ. The special characteristics of near infra-red window such as minimal auto-fluorescence, low light scattering, and absorption of biomolecules in tissue converge to form an attractive modality for cancer imaging. Imparting molecular fluorescence as an exogenous contrast agent is the most beneficial attribute of NIRF light as a clinical imaging technology. Additionally, many such agents also display therapeutic potentials as photo-thermal agents, thus meeting the dual purpose of imaging and therapy. Here, we primarily discuss molecular imaging and therapeutic potentials of two such classes of materials, i.e., inorganic NIR dyes and metallic gold nanoparticle based materials.

Highlights

  • Molecular imaging (MI) reveals biological information that is relevant for the clinical understanding of disease processes, and carries enormous relevance for patient care

  • This study indicated that gold nanoparticles have an inherent two-photon luminescence imaging (TPL) property, and can be functionalized for selective targeting, visualization, and hyperthermia mediated extirpation of cancer cells [53]

  • The challenges in developing NPs for use in MI may be overcome in the near future

Read more

Summary

Introduction

Molecular imaging (MI) reveals biological information that is relevant for the clinical understanding of disease processes, and carries enormous relevance for patient care. Imaging of cancer lesions for simultaneous localization of the site as well as obtaining functional information for oncogenic protein molecules is of great clinical significance. Another aspect where MI can play a greater role is surgical interventions, which remains the mainstay, at least in oncology, for most complicated indications in spite of the improvement in other medications. The imaging community has pursued various avenues by translating spectral imaging modalities from extant preoperative techniques that include single photon emission computed tomography (SPECT) and positron emission tomography (PET) [1] Both imaging modalities have been explored with great success, cost, accessibility, and use of ionizing radiation associated with these techniques imparts limitations on their real-time translation. Further therapeutic potentials of such materials with special reference to photothermal therapy (PTT) are discussed

The Near-Infrared Window
Requisite Design Parameters of Imaging Probes
Methods for Obtaining Tissue Specific Imaging
Nanoparticle-Based Bio-Conjugates
Small Molecule-Based Bio-Conjugates
Drug Delivery
Physical and Optical Properties of Gold Nanoparticles
Gold Nanostars
Gold Nanospheres
Gold Nanorods
Molecular Imaging Methodologies Using NIRF Signature
Fluorescence Imaging Tomography
Advances
Time Domain NIRF Imaging
Findings
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call